Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	23.71B +121.9%
Revenue (ttm)	1.69B -14.9%
Net Income	495.08M +27.8%
EPS	0.68 +33.4%
Shares Out	733.37M
PE Ratio	51.52
Forward PE	58.26
Dividend	0.12 (0.34%)
Ex-Dividend Date	Aug 14, 2025

Volume	27,820,943
Open	34.67
Previous Close	35.17
Day's Range	33.50 - 36.08
52-Week Range	16.37 - 45.95
Beta	0.92
Analysts	Buy
Price Target	33.26 (-0.89%)
Earnings Date	Aug 28, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,649
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2025, SHA:603127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.